Alnylam Pharmaceuticals
Leila Noetzli has extensive experience in research and clinical settings, focusing on platelet production, thrombocytopenia, and iron overload in patients with blood disorders. With a background in Human Biology and a PhD in Human Medical Genetics and Genomics, Leila has worked at various prestigious institutions such as Alnylam Pharmaceuticals, Brigham and Women's Hospital, and Children's Hospital Los Angeles. Leila is skilled in molecular and cell biology, sequencing techniques, and presenting research findings at conferences and in publications.
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.